Clozapine in patients with chronic schizophrenia: Serum level, EEG and memory performance

Pharmacopsychiatry

Volumn 35, Issue 5, 2002, Pages 190-194

  Adler, Georg ^a   Grieshaber, S ^a   Faude, V ^a   Thebaldi, B ^a   Dressing, H ^b  

^a Clinical Neurophysiology Service   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; REBOXETINE; SERTRALINE;

ADULT; ALERTNESS; AMNESIA; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; MEMORY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; TASK PERFORMANCE;

ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MEMORY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0036746319     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34120     Document Type: Article

References (34)

1. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacol 1993; 9: 117-124
2. Conners CK. The continuous performance test. Toronto: Multi-Health Systems, 1995
3. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of central cholinergic innervation. Science 1983; 219: 1184-1190
4. Daniel DG, Goldberg TE, Weinberger DR, Kleinman JE, Pickar D, Lubick LJ, Williams TS. Different side effect profiles of risperidone and clozapine in 20 outpatients schizophrenia of schizoaffective disorder: a pilot study. Am J Psychiatry 1996; 153: 417-419
5. Drachman DA, Leavitt J. Human memory and the cholinergic system. Arch Neurol 1974; 30: 113-121
6. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
7. Freudenreich O, Weiner RD, McEvoy JP. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiat 1997; 42: 132-137
8. Gattaz WF, Mayer S, Ziegler P, Platz M, Gasser T. Hypofrontality on topographic EEG in schizophrenia: correlations with neuropsychological and psychopathological parameters. Eur Arch Psychiat Clin Neurosci 1992; 241: 328-332
9. Goldberg TE, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D, Schulz SC, Weinberger DR. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiat 1993; 162: 43-48
10. Goldberg TE, Weinberger DR. The effects of clozapine on neurocognition: an overview. J Clin Psychiatr 1994; 55 (Suppl B): 88-90
11. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia. Am J Psychiatry 1996; 153: 321-330
12. Günther W, Baghai T, Naber D, Spatz R, Hippius H. EEG alterations and seizures during treatment with clozapine. Pharmacopsychiat 1993; 26: 69-74
13. Haring C, Neudorfer C, Schwitzer J, Hummer M, Saria A, Hinterhuber H, Fleischhacker WW. EEG alterations in patients treated with clozapine in relation to plasma levels. Psychopharmacology 1994; 114: 97-100
14. Helmstaedter C, Durwen HF. VLMT: Verbaler Lern- und Merkfähig-keitstest. Schweiz Arch Neurol Psychiat 1990; 141: 21-30
15. Ihl R, Dierks T, Martin E-M, Frölich L, Maurer K. Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biol Psychiat 1996; 39: 319-325
16. Katznelson RD. EEG recording, electrode placement and aspects of generator localization. In Nuñez PL (ed). Electrical fields of the brain New York: Oxford University Press:, 1981
17. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276
18. Lee MA, Jayathilake K, Meltzer HY. A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia. Schizophr Res 1999; 37: 1-11
19. Malow BA, Reese KB, Sato S, Bogard HJ, Malhotra AK, Su T-P, Pickar D. Spectrum of EEG abnormalities during clozapine treatment. Electroenceph Clin Neurophysiol 1994; 91: 205-211
20. McGurk SR. The effects of clozapine on cognitive functioning in schizophrenia. J Clin Psychiatry 1999; 60 (Suppl. 12): 24-29
21. Meltzer HY, McGurk SR. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 1999; 25: 233-255
22. Metherate R, Cox CL, Ashe JH. Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine. J Neurosci 1992; 12: 4701-4711
23. Miller JL, Hiley CR. Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepine. Nauyn-Schmiedeberg's Arch Pharmacol 1976; 292: 289-293
24. Nordström AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. D1, D2 and 5-HT2-receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiat 1995; 152: 1444-1449
25. Rey A. L'examen de clinique en psychologie. Paris: Presses Universitaires de France, 1964
26. Richelson E. Neuroleptics and neurotransmitter receptors. Psychiatr Ann 1980; 10: 21-26
27. Saletu B, Grunberger J, Linzmayer L, Anderer P. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry. Pharmacopsychiat 1987; 20: 12-27
28. Schuld A, Kühn M, Haack M, Kraus T, Hinze-Selch D, Lechner C, Pollmächter T. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiat 2000; 33: 109-111
29. Semlitsch HV, Anderer P, Saletu B, Schuster P, Presslich O. A solution for reliable and valid reduction of ocular artefacts to the P300 ERP. Psychophysiology 1986; 23: 695-703
30. Taylor LB. Psychological assessment of neurosurgical patients. In Rasmussen T, Marino R (eds). Functional neurosurgery New York: Raven Press, 1979
31. Tracy JI, Monaco CA, Abraham G, Josiassen RC, Pollock BG. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine of risperidone. J Clin Psychiatry 1998; 59: 184-188
32. Wechsler D. Psychological Corporation. New York: 1981
33. Weigmann H, Hartter S, Fischer V, Dahmen N, Hiemke C. Distribution of clozapine and desmethylclozapine between blood and brain in rats. Eur Neuropsychopharmacol 1999: 9: 253-256
34. Welch J, Manschreck T, Redmond D. Clozapine-induced seizures and EEG changes. J Neuropsychiat Clin Neurosci 1994; 6: 250-256